logging in or signing up A national Pandemic Action Plan for flu Sidihaiba71 Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 228 Category: Entertainment License: All Rights Reserved Like it (6) Dislike it (1) Added: April 16, 2009 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... By: Sidihaiba71 (37 month(s) ago) thank U Harman I never thought that this presentation would be as useful as it is now giving the current (potential) outbreak of the swine flu. It was interesting mapping those data of the CDC and see how unprepared we are to face up the challenge . Saving..... Post Reply Close Saving..... Edit Comment Close By: Harman (37 month(s) ago) good presentation Saving..... Post Reply Close Saving..... Edit Comment Close Premium member Presentation Transcript Slide 1: Statistical Analysis Project By National College MBA Students Mohamed El Mokhtar and Louai Al Meqbeli Project Charter : Project Charter Project: The Establishment of a National Pandemic Action Plan for Influenza in the US. Organization: Center for Disease Control Target Completion date: December 2013 Team Members: Mohamed Sidi Haiba and Louai El Meqbeli Scope: The project will analyze the flaws of the existing process and propose alternative solutions to improve it. Project Charter Cont’d : Project Charter Cont’d Stakeholders: Physicians Patients Healthcare Providers Employers General Population Government Project Charter – Objectives : Project Charter – Objectives The Stated Goal: Increasing the supply and capacity of delivery of influenza vaccines The Strategies Identified: Developing an immunization policy to increase the demand for seasonal vaccines by an average rate of 10% a year. Increasing influenza vaccine production capacity accordingly. Promoting research and development for new influenza vaccines Project Charter – ObjectivesDeveloping an immunization policy to increase demand for seasonal vaccines : Project Charter – ObjectivesDeveloping an immunization policy to increase demand for seasonal vaccines Map the landscape Estimate the disease burden Develop regional plans of action and mobilize resources Encourage international coordination between between countries and regions of the world Project Charter – ObjectivesIncreasing influenza vaccine production capacity : Project Charter – ObjectivesIncreasing influenza vaccine production capacity The three most valuable options identified by WHO experts Include: 1.continuing to promote seasonal influenza vaccine programmers, supporting the industry to sustain production capacity beyond seasonal demand and enabling some vaccine production facilities to change, at the onset of a pandemic, from producing inactivated vaccines to live attenuated vaccines. Project Charter – ObjectivesPromote research and development for new influenza vaccines : Project Charter – ObjectivesPromote research and development for new influenza vaccines Develop more effective influenza vaccines using new technologies. The ideal product profile is a vaccine which is: safe and highly protective, preferably in all target groups, including infants, the elderly, pregnant women and immuno-suppressed individuals; is easily and economically produced on a large scale; is effective – preferably with a low dose of antigen; is delivered, ideally, as a single dose Deployment Model Need Drivers CTQs Requirements : Deployment Model Need Drivers CTQs Requirements Improving the uptake of the influenza vaccines in the USA Seasonal clinic Mobile Staff Client recall reminder Providers feedback Media campaign Enhance efficacy of exiting vaccines and promote research for new ones Slide 9: Mapping The Process Through Analysis Of Existing Data Mapping the existing process : Mapping the existing process Influenza Vaccine Doses distributed, United States 1964-2004. % of persons aged = 65 years who reported receiving Vaccination during the preceding 12 months, by race/ethnicity and survey year- national health interview survey, US 1989-2003. % of persons aged 18-64 years who reported receiving influenza vaccination during the preceding 12 months, by race/ethnicity and survey year-national health interview survey, US 1989-2003. Cumulative Monthly Influenza Vaccine Distribution for 1999, 2000, 2001, 2002, 2003-04, 2004-05. % of influenza Vaccination by month, selected priority US populations, BRFSS 2004-05 Determining the process variation : Determining the process variation To achieve this objective, one needs first to examine the nature of the cause effects we are dealing with. Are they common or special? Given the data we have so far and the fact that our strategic approach is already known (improvement process), we know in advance that our variation type is stable and our cause effects are common. Identifying the root causes : Identifying the root causes Based on the analysis of existing data we have identified several root causes, but the most important are: Lack of education Difficulties to access Cost Vaccine shortages Gaps in R & D Proposed Solutions : Proposed Solutions Creating a robust and effective supply and delivery chain. Developing a stockpiles of vaccines. Resolving policy regulatory and coordination Broaden access to vaccination e.g. workplace, community, pharmacies, seasonal clinics. Raise the awareness of the public about the importance of vaccination (public information). Mandate employers to offer vaccine free of charge or at an affordable cost (on site if possible). Extend the requirement to public schools, nursing homes, kindergarten. Cont’d Solutions : Cont’d Solutions Enhance demand among vulnerable segments of the population “elderly people, infants, pregnant women, children etc…” Extend the critical period of coverage beyond December. Link Influenza vaccination with the delivery of other vaccination among adolescents. Implementation Process : Implementation Process Summary : Summary The availability of data is a crucial step in statistical analysis. Although, we Were unable to obtain/collect all the data we needed, we had enough to kick start our mapping process and devise some of our proposed solutions. The three most valuable proposals identified by WHO experts include: continuing to promote seasonal influenza vaccine programmers, supporting the industry to sustain production capacity beyond seasonal demand and enabling some vaccine production facilities to change, at the onset of a pandemic, from producing inactivated vaccines to live attenuated vaccines. Finally, in order for the process to be efficiently implemented and to take root In the long run, the improvements achieved need to be maintained and Ultimately institutionalized. In this regard the institution of a process control level is of great importance. Critique of the sources: : Critique of the sources: Statistical Thinking (improving business performance) by R. Hoerl and R Snee Department of Health & Human Services HHS www.who.org Http://www.isixsigma.com/library/content/c001211a.asp. www.dtic.mil/ndia/2003CMMI/Facemire.ppt Thank you for your attention! Now do you have any Questions ? : Thank you for your attention! Now do you have any Questions ? You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.
A national Pandemic Action Plan for flu Sidihaiba71 Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 228 Category: Entertainment License: All Rights Reserved Like it (6) Dislike it (1) Added: April 16, 2009 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... By: Sidihaiba71 (37 month(s) ago) thank U Harman I never thought that this presentation would be as useful as it is now giving the current (potential) outbreak of the swine flu. It was interesting mapping those data of the CDC and see how unprepared we are to face up the challenge . Saving..... Post Reply Close Saving..... Edit Comment Close By: Harman (37 month(s) ago) good presentation Saving..... Post Reply Close Saving..... Edit Comment Close Premium member Presentation Transcript Slide 1: Statistical Analysis Project By National College MBA Students Mohamed El Mokhtar and Louai Al Meqbeli Project Charter : Project Charter Project: The Establishment of a National Pandemic Action Plan for Influenza in the US. Organization: Center for Disease Control Target Completion date: December 2013 Team Members: Mohamed Sidi Haiba and Louai El Meqbeli Scope: The project will analyze the flaws of the existing process and propose alternative solutions to improve it. Project Charter Cont’d : Project Charter Cont’d Stakeholders: Physicians Patients Healthcare Providers Employers General Population Government Project Charter – Objectives : Project Charter – Objectives The Stated Goal: Increasing the supply and capacity of delivery of influenza vaccines The Strategies Identified: Developing an immunization policy to increase the demand for seasonal vaccines by an average rate of 10% a year. Increasing influenza vaccine production capacity accordingly. Promoting research and development for new influenza vaccines Project Charter – ObjectivesDeveloping an immunization policy to increase demand for seasonal vaccines : Project Charter – ObjectivesDeveloping an immunization policy to increase demand for seasonal vaccines Map the landscape Estimate the disease burden Develop regional plans of action and mobilize resources Encourage international coordination between between countries and regions of the world Project Charter – ObjectivesIncreasing influenza vaccine production capacity : Project Charter – ObjectivesIncreasing influenza vaccine production capacity The three most valuable options identified by WHO experts Include: 1.continuing to promote seasonal influenza vaccine programmers, supporting the industry to sustain production capacity beyond seasonal demand and enabling some vaccine production facilities to change, at the onset of a pandemic, from producing inactivated vaccines to live attenuated vaccines. Project Charter – ObjectivesPromote research and development for new influenza vaccines : Project Charter – ObjectivesPromote research and development for new influenza vaccines Develop more effective influenza vaccines using new technologies. The ideal product profile is a vaccine which is: safe and highly protective, preferably in all target groups, including infants, the elderly, pregnant women and immuno-suppressed individuals; is easily and economically produced on a large scale; is effective – preferably with a low dose of antigen; is delivered, ideally, as a single dose Deployment Model Need Drivers CTQs Requirements : Deployment Model Need Drivers CTQs Requirements Improving the uptake of the influenza vaccines in the USA Seasonal clinic Mobile Staff Client recall reminder Providers feedback Media campaign Enhance efficacy of exiting vaccines and promote research for new ones Slide 9: Mapping The Process Through Analysis Of Existing Data Mapping the existing process : Mapping the existing process Influenza Vaccine Doses distributed, United States 1964-2004. % of persons aged = 65 years who reported receiving Vaccination during the preceding 12 months, by race/ethnicity and survey year- national health interview survey, US 1989-2003. % of persons aged 18-64 years who reported receiving influenza vaccination during the preceding 12 months, by race/ethnicity and survey year-national health interview survey, US 1989-2003. Cumulative Monthly Influenza Vaccine Distribution for 1999, 2000, 2001, 2002, 2003-04, 2004-05. % of influenza Vaccination by month, selected priority US populations, BRFSS 2004-05 Determining the process variation : Determining the process variation To achieve this objective, one needs first to examine the nature of the cause effects we are dealing with. Are they common or special? Given the data we have so far and the fact that our strategic approach is already known (improvement process), we know in advance that our variation type is stable and our cause effects are common. Identifying the root causes : Identifying the root causes Based on the analysis of existing data we have identified several root causes, but the most important are: Lack of education Difficulties to access Cost Vaccine shortages Gaps in R & D Proposed Solutions : Proposed Solutions Creating a robust and effective supply and delivery chain. Developing a stockpiles of vaccines. Resolving policy regulatory and coordination Broaden access to vaccination e.g. workplace, community, pharmacies, seasonal clinics. Raise the awareness of the public about the importance of vaccination (public information). Mandate employers to offer vaccine free of charge or at an affordable cost (on site if possible). Extend the requirement to public schools, nursing homes, kindergarten. Cont’d Solutions : Cont’d Solutions Enhance demand among vulnerable segments of the population “elderly people, infants, pregnant women, children etc…” Extend the critical period of coverage beyond December. Link Influenza vaccination with the delivery of other vaccination among adolescents. Implementation Process : Implementation Process Summary : Summary The availability of data is a crucial step in statistical analysis. Although, we Were unable to obtain/collect all the data we needed, we had enough to kick start our mapping process and devise some of our proposed solutions. The three most valuable proposals identified by WHO experts include: continuing to promote seasonal influenza vaccine programmers, supporting the industry to sustain production capacity beyond seasonal demand and enabling some vaccine production facilities to change, at the onset of a pandemic, from producing inactivated vaccines to live attenuated vaccines. Finally, in order for the process to be efficiently implemented and to take root In the long run, the improvements achieved need to be maintained and Ultimately institutionalized. In this regard the institution of a process control level is of great importance. Critique of the sources: : Critique of the sources: Statistical Thinking (improving business performance) by R. Hoerl and R Snee Department of Health & Human Services HHS www.who.org Http://www.isixsigma.com/library/content/c001211a.asp. www.dtic.mil/ndia/2003CMMI/Facemire.ppt Thank you for your attention! Now do you have any Questions ? : Thank you for your attention! Now do you have any Questions ?